| 621 |
KADCYLA 100 MG |
TRASTUZUMAB EMTANSINE 106MG |
POWDER FOR INFUSION |
Vial |
METASTATIC BREAST CANCER |
NULL |
DKSH LAOS COMPANY LIMITED |
F. HOFFMANN - LA ROCHE LTD. |
SWITZERLAND |
STEP 1: RECEIVE (RENEW) |
08 I 4774/19 |
22-JUL-2022 |
21-JUL-2025 |
View |
| 622 |
KADCYLA VIALS 160 MG |
TRASTUZUMAB EMTASINE 171 MG/VIALS |
POWDER FOR INFUSION |
VIAL |
METASTATIC BREAST CANCER |
NULL |
DKSH LAOS COMPANY LIMITED |
F. HOFFMANN-LA ROCHE AG |
SWITZERLAND |
STEP 1: RECEIVE (RENEW) |
06 I 4716/19 |
5-AUG-2022 |
4-AUG-2025 |
View |
| 623 |
ANDROGEL 16.2 MG/G |
TESTOSTERONE 1.62 MG/100G |
GEL |
CANISTER |
IN ADULTS AS REPLACEMENT THERAPY FOR MALE HYPOGONADISM WHEN TESTOSTERONE DEFICIENCY HAS BEEN CLINICALLY AND BIOLOGICALLY CONFIRMED |
NULL |
EXAMED CO.,LTD |
LABORATOIRE BESINS INTERNATIONAL |
FRANCE |
CERTIFICATE RELEASED |
04 I 5731/24 |
2024-04-26 |
2027-04-25 |
View |
| 624 |
ANDROGEL 50 MG |
TESTOSTERONE 0.050 G |
GEL |
SACHET |
REPLACEMENT THERAPY FOR MALE HYPOGONADISM, WHEN TESTOSTERONE DEFICIENCY HAS BEEN CONFIRMED BY CLINICAL FEATURES AND BIOCHEMICAL TESTS |
NULL |
EXAMED CO.,LTD |
BESINS MANUFACTURING BELGIUM |
BELGIUM |
CERTIFICATE RELEASED |
10 I 3585/11 |
9-JUL-2024 |
8-JUL-2027 |
View |
| 625 |
CEF-OD-SUSPENSION 100MG/5ML |
CEFIXIME (AS TRIHYDRATE) 100 MG / 5ML |
POWDER FOR ORAL SUSPENSION |
BOTTLE |
TREATMENT OF OTITIS MEDIA, PHARYNGITIS AND TONSILLITIS, UNCOMPLICATED URINARY TRACT INFECTION, ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS, UNCOMPLICATED GONORRHEA. |
NULL |
EXAMED CO.,LTD |
PHARMASOL (PVT.) LTD. |
PAKISTAN |
CERTIFICATE RELEASED |
04 I 4386/18 |
21-MAY-2025 |
20-MAY-2030 |
View |
| 626 |
CIPROMEN TABLET 500 MG |
CIPROFLOXACIN (AS HCL) 500 MG |
FILM COATED TABLET |
ALU-ALU BLISTER |
LOWER RESPIRATORY TRACT, CHRONIC SUPPURATIVE OTITIS MEDIA, ACUTE EXACERBATION OF CHRONIC SINUSITIS, UNCOMPLICATED ACUTE CYSTITIS, ACUTE PYELONEPHRITIS, COMPLICATED URINARY TRACT INFECTION, BACTERIAL PROSTATITIS, GENITAL TRACT INFECTION |
NULL |
EXAMED CO.,LTD |
CCL PHARMACEUTICALS (PVT.) LTD. |
PAKISTAN |
CERTIFICATE RELEASED |
08 I 5590/23 |
05-SEP-2023 |
04-SEP-2026 |
View |
| 627 |
CRESTAT TABLET 10 MG |
ROSUVASTATIN AS CALCIUM 10 MG |
FILM-COATED TABLETS |
ALU-ALU |
AS AN ADJUNCT TO DIET TO REDUCE ELEVATED TOTAL-C, LDL-C, APOB, NON HDL-C, TG LEVELS AND TO INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA AND MIXED DYSLIPIDEMIA. AS AN ADJUNCT TO DIET FOR THE TREATMENT OF PATIENTS WITH ELEVATED SERUM TG LEVEL (FREDRICKSON TYPE IV) |
NULL |
EXAMED CO.,LTD |
CCL PHARMACEUTICALS (PVT.) LTD. |
PAKISTAN |
CERTIFICATE RELEASED |
04 I 4380/18 |
21-MAY-2025 |
20-MAY-2030 |
View |
| 628 |
CRESTAT TABLET 20 MG |
ROSUVASTATIN AS CALCIUM 20 MG |
FILM-COATED TABLETS |
ALU-ALU |
AS AN ADJUNCT TO DIET TO REDUCE ELEVATED TOTAL-C, LDL-C, APOB, NON HDL-C, TG LEVELS AND TO INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA AND MIXED DYSLIPIDEMIA. AS AN ADJUNCT TO DIET FOR THE TREATMENT OF PATIENTS WITH ELEVATED SERUM TG LEVEL (FREDRICKSON TYPE IV) |
NULL |
EXAMED CO.,LTD |
CCL PHARMACEUTICALS (PVT.) LTD. |
PAKISTAN |
CERTIFICATE RELEASED |
04 I 4381/18 |
21-MAY-2025 |
20-MAY-2030 |
View |
| 629 |
CRESTAT TABLET 5 MG |
ROSUVASTATIN AS CALCIUM 5 MG |
FILM-COATED TABLETS |
ALU-ALU |
AS AN ADJUNCT TO DIET TO REDUCE ELEVATED TOTAL-C, LDL-C, APOB, NON HDL-C, TG LEVELS AND TO INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA AND MIXED DYSLIPIDEMIA. AS AN ADJUNCT TO DIET FOR THE TREATMENT OF PATIENTS WITH ELEVATED SERUM TG LEVEL (FREDRICKSON TYPE IV) |
NULL |
EXAMED CO.,LTD |
CCL PHARMACEUTICALS (PVT.) LTD. |
PAKISTAN |
CERTIFICATE RELEASED |
04 I 4379/18 |
21-MAY-2025 |
20-MAY-2030 |
View |
| 630 |
FELBEX 20 MG TABLETS |
PIROXICAM BETA CYCLODEXTRIN EQ.TO PIROXICAM 20 MG |
TABLET |
ALU-ALU BLISTER |
Acute painful musculoskeletal conditions |
NULL |
EXAMED CO.,LTD |
MARTIN DOW LTD |
PAKISTAN |
CERTIFICATE RELEASED |
01 I 5848/25 |
23-JAN-2025 |
22-JAN-2030 |
View |
